We are live on ! Find out more
PCP

Pacific Capital Partners Portfolio holdings

AUM $116M
1-Year Est. Return 24.59%
This Fund
S&P 500
This Quarter Est. Return
-1.6%
1 Year Est. Return
+24.59%
3 Year Est. Return
+49.79%
5 Year Est. Return
10 Year Est. Return
AUM
$151M
AUM Growth
-$1.76M
Cap. Flow
+$2.98M
Cap. Flow %
1.97%
Top 10 Hldgs %
48.52%
Holding
63
New
5
Increased
15
Reduced
8
Closed
5

Top Buys

Rank Stock Value
1
AVTR icon
Avantor
AVTR
+$2.41M
2
ACA icon
Arcosa
ACA
+$2.29M
3
LAB icon
Standard BioTools
LAB
+$1.83M
4
PYPL icon
PayPal
PYPL
+$1.75M
5
EPAM icon
EPAM Systems
EPAM
+$1.07M

Top Sells

Rank Stock Value
1
WWD icon
Woodward
WWD
+$3.83M
2
KKR icon
KKR & Co
KKR
+$2.01M
3
NEE icon
NextEra Energy
NEE
+$1.92M
4
RSG icon
Republic Services
RSG
+$1.42M
5
VSTS icon
Vestis
VSTS
+$964K

Sector Composition

Rank Sector Weight
1 Healthcare 50.01%
2 Industrials 26%
3 Financials 9.58%
4 Materials 5.34%
5 Consumer Discretionary 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
51
HCA Healthcare
HCA
$88.1B
$802K 0.53%
2,495
LULU icon
52
lululemon athletica
LULU
$13B
$644K 0.43%
2,156
+451
+26% +$151K
ECL icon
53
Ecolab
ECL
$79.6B
$631K 0.42%
2,653
-862
-25% -$199K
TNDM icon
54
Tandem Diabetes Care
TNDM
$1.62B
$616K 0.41%
15,282
NKE icon
55
Nike
NKE
$59.3B
$601K 0.4%
7,972
AMED
56
DELISTED
Amedisys
AMED
$593K 0.39%
6,457
CVS icon
57
CVS Health
CVS
$120B
$559K 0.37%
9,471
ALGN icon
58
Align Technology
ALGN
$11.3B
$444K 0.29%
1,839
BLK icon
59
Blackrock
BLK
$178B
-365
Closed -$304K
GH icon
60
Guardant Health
GH
$22.1B
-10,329
Closed -$213K
KKR icon
61
KKR & Co
KKR
$96.9B
-20,000
Closed -$2.01M
NEE icon
62
NextEra Energy
NEE
$178B
-30,000
Closed -$1.92M
VSTS icon
63
Vestis
VSTS
$1.69B
-50,000
Closed -$964K

Similar funds

Pacific Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Pacific Capital Partners held 63 positions worth $151M, down 1.2% from $153M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Pacific Capital Partners's Q2 2024 filing shows 5 new, 15 increased, 8 reduced and 5 closed positions. Its largest new stake was Arcosa: 27,500 shares worth $2.29M. The largest sale was Woodward, an estimated $3.83M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 47% a quarter earlier, followed by Industrials and Financials.

  • Pacific Capital Partners's largest Q2 2024 buy was Arcosa: 27,500 shares worth $2.29M.
  • Pacific Capital Partners added most to Avantor in Q2 2024, an estimated $2.41M increase.
  • Pacific Capital Partners's biggest Q2 2024 reduction was Woodward, cutting an estimated $3.83M.
  • Pacific Capital Partners fully exited KKR & Co in Q2 2024, selling an estimated $2.01M.
  • Pacific Capital Partners's ten largest holdings make up 49% of its $151M portfolio in Q2 2024.
  • Pacific Capital Partners opened 5 new positions and closed 5 in Q2 2024.
  • Pacific Capital Partners's portfolio value fell 1.2% quarter-over-quarter to $151M.

Based on Pacific Capital Partners's 13F filing for Q2 2024, filed 8 May 2025.